DROSPIRENONE AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Drospirenone And Ethinyl Estradiol, and when can generic versions of Drospirenone And Ethinyl Estradiol launch?
Drospirenone And Ethinyl Estradiol is a drug marketed by Barr, Glenmark Pharms Ltd, Hetero Labs, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs, Apotex, Dr Reddys Labs Sa, Lupin Ltd, and Naari Pte Ltd. and is included in sixteen NDAs.
The generic ingredient in DROSPIRENONE AND ETHINYL ESTRADIOL is drospirenone; ethinyl estradiol. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Drospirenone And Ethinyl Estradiol
A generic version of DROSPIRENONE AND ETHINYL ESTRADIOL was approved as drospirenone; ethinyl estradiol by DR REDDYS LABS SA on September 7th, 2010.
Summary for DROSPIRENONE AND ETHINYL ESTRADIOL
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 10 |
Clinical Trials: | 32 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DROSPIRENONE AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for DROSPIRENONE AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Women's Hospital School Of Medicine Zhejiang University | Phase 4 |
University of California, San Francisco | Phase 4 |
American University of Beirut Medical Center | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for DROSPIRENONE AND ETHINYL ESTRADIOL
US Patents and Regulatory Information for DROSPIRENONE AND ETHINYL ESTRADIOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL | 078515-001 | Mar 30, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL | 078833-001 | Nov 28, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hlthcare | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL | 203291-001 | Jul 18, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hetero Labs | DROSPIRENONE AND ETHINYL ESTRADIOL | drospirenone; ethinyl estradiol | TABLET;ORAL-28 | 213034-001 | Jan 24, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |